Proteinuria lowering needs a multifactorial and individualized approach to halt progression of renal disease

Paul E. de Jong*, Gerjan Navis

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

5 Citaten (Scopus)

Samenvatting

This Practice Point commentary discusses the implementation of an intensive, multifactorial intervention in patients who had proteinuria >3g/day despite treatment with angiotensin-converting-enzyme inhibitors. In their 'Remission Clinic' in Bergamo, Italy, Ruggenenti et al. implemented an individual titration regimen using ramipril 5-10 mg/day, losartan 50-100 mg/day, verapamil 80-120 mg/day and atorvastatin 10-20 mg/day in successive steps, aiming for a low blood pressure target of

Originele taal-2English
Pagina's (van-tot)654-655
Aantal pagina's2
TijdschriftNATURE CLINICAL PRACTICE NEPHROLOGY
Volume4
Nummer van het tijdschrift12
DOI's
StatusPublished - dec-2008

Citeer dit